Gensco Company Profile
What is the competitive landscape for GENSCO
GENSCO has one approved drug.
There is one US patent protecting GENSCO drugs.
Summary for Gensco
| US Patents: | 1 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Gensco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gensco | RIZAFILM | rizatriptan benzoate | FILM;ORAL | 205394-002 | Feb 26, 2026 | DISCN | Yes | No | 9,301,948 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Gensco | RIZAFILM | rizatriptan benzoate | FILM;ORAL | 205394-001 | Apr 14, 2023 | RX | Yes | Yes | 9,301,948 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Gensco Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Russian Federation | 2016106907 | ⤷ Start Trial |
| European Patent Office | 3427732 | ⤷ Start Trial |
| European Patent Office | 3027179 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Gensco Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0497512 | 98C0037 | France | ⤷ Start Trial | PRODUCT NAME: RIZATRIPTAN BENZOATE; REGISTRATION NO/DATE IN FRANCE: NL 23 695 DU 19980817; REGISTRATION NO/DATE AT EEC: 21 815 DU 19980211 |
| 0497512 | 9891028-4 | Sweden | ⤷ Start Trial | PRODUCT NAME: RIZATRIPTAN, N.N-DIMETYL-2-(5-(1, 2, 4-TRIAZOL-1-YLMETYL)-1H-INDOL-3-YL)ET)-1H-I, EVENTUELLT I FORM AV ETT FARMACEUTISKT GODTAGBART SALT, SPECIELLT DA RIZATRIPTANBENSOAT |
| 0497512 | SPC/GB98/035 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: RIZATRIPTAN, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, ESPECIALLY RIZATRIPTAN BENZOATE; REGISTERED: NL 21815 19980211; NL 21816 19980211; NL 21817 19980211; NL 21818 19980211; UK 00025/0369 19980624; UK 00025/0370 19980624; UK 00025/0371 19980624; UK 00025/0372 19980624 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
